Skip to main content

Table 2 Observed level of plasma AD biomarkers by group at baseline, 3, and 6 months

From: Feasibility and preliminary effects of exercise interventions on plasma biomarkers of Alzheimer’s disease in the FIT-AD trial: a randomized pilot study in older adults with Alzheimer’s dementia

 

Baseline

3 months

6 months

N

Mean (S.D.)

N

Mean (S.D.)

N

Mean (S.D.)

Stretching

 Plasma Ab42/40 ratio

8

0.053 (0.013)

8

0.055 (0.011)

8

0.054 (0.010)

 t-tau

8

0.872 (0.271)

8

0.865 (0.283)

8

0.851 (0.287)

 p-tau181

7

2.660 (1.338)

8

2.729 (1.119)

8

3.269 (1.491)

Cycling

 Plasma Ab42/40 ratio

18

0.055 (0.010)

15

0.054 (0.010)

17

0.054 (0.011)

 t-tau

18

0.791 (0.184)

15

0.789 (0.165)

17

0.716 (0.242)

 p-tau181

15

2.505 (1.430)

15

2.561 (1.401)

16

2.606 (1.716)